Cancer biomarker discovery is improved by accounting for variability in general levels of drug sensitivity in pre-clinical models

Paul Geeleher, Nancy J. Cox, R. Stephanie Huang

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Cancer biomarker discovery is improved by accounting for variability in general levels of drug sensitivity in pre-clinical models'. Together they form a unique fingerprint.

Earth & Environmental Sciences

Agriculture & Biology

Medicine & Life Sciences